<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dose Response</journal-id><journal-id journal-id-type="iso-abbrev">Dose Response</journal-id><journal-id journal-id-type="publisher-id">DOS</journal-id><journal-id journal-id-type="hwp">spdos</journal-id><journal-title-group><journal-title>Dose-Response</journal-title></journal-title-group><issn pub-type="epub">1559-3258</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5598801</article-id><article-id pub-id-type="doi">10.1177/1559325817723731</article-id><article-id pub-id-type="publisher-id">10.1177_1559325817723731</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen </plain></SENT>
</text></SecTag></article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7070-0342</contrib-id><name><surname>Mehboob</surname><given-names>Huma</given-names></name><xref ref-type="aff" rid="aff1-1559325817723731">1</xref><xref ref-type="corresp" rid="corresp1-1559325817723731"/></contrib><contrib contrib-type="author"><name><surname>Tahir</surname><given-names>Imtiaz Mahmood</given-names></name><xref ref-type="aff" rid="aff2-1559325817723731">2</xref></contrib><contrib contrib-type="author"><name><surname>Iqbal</surname><given-names>Tahira</given-names></name><xref ref-type="aff" rid="aff3-1559325817723731">3</xref></contrib><contrib contrib-type="author"><name><surname>Saleem</surname><given-names>Sadaf</given-names></name><xref ref-type="aff" rid="aff1-1559325817723731">1</xref></contrib><contrib contrib-type="author"><name><surname>Perveen</surname><given-names>Sofia</given-names></name><xref ref-type="aff" rid="aff1-1559325817723731">1</xref></contrib><contrib contrib-type="author"><name><surname>Farooqi</surname><given-names>Aboubakker</given-names></name><xref ref-type="aff" rid="aff4-1559325817723731">4</xref></contrib></contrib-group><aff id="aff1-1559325817723731">
<label>1</label>Department of Biochemistry, Government College Women University, Faisalabad, Pakistan</aff><aff id="aff2-1559325817723731">
<label>2</label>College of Allied Health Professionals, Government College University, Faisalabad, Pakistan</aff><aff id="aff3-1559325817723731">
<label>3</label>Department of Biochemistry, University of Agriculture Faisalabad, Faisalabad, Pakistan</aff><aff id="aff4-1559325817723731">
<label>4</label>College of Pharmacy, Government College University, Faisalabad, Pakistan</aff><author-notes><corresp id="corresp1-1559325817723731">Huma Mehboob, Department of Biochemistry, Government College Women University, Madina Town, Faisalabad 38000, Pakistan. Email: <email>moona_farooqi21@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="collection"><season>Jul-Sep</season><year>2017</year></pub-date><volume>15</volume><issue>3</issue><elocation-id>1559325817723731</elocation-id><history><date date-type="received"><day>3</day><month>2</month><year>2017</year></date><date date-type="accepted"><day>21</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s) 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>Interindividual variability in polymorphic uridine diphosphate-glucuronosyltransferase 1A1 (UGT1A1) ascribed to genetic diversity is associated with relative glucuronidation level among individuals. </plain></SENT>
<SENT sid="2" pm="."><plain>The present research was aimed to study the effect of 2 important single nucleotide polymorphisms (SNPs; rs8330 and rs10929303) of UGT1A1 gene on glucuronidation status of acetaminophen in healthy volunteers (n = 109). </plain></SENT>
<SENT sid="3" pm="."><plain>Among enrolled volunteers, 54.13% were male (n = 59) and 45.87% were female (n = 50). </plain></SENT>
<SENT sid="4" pm="."><plain>The in vivo activity of UGT1A1 was investigated by high-performance liquid chromatography-based analysis of glucuronidation status (ie, acetaminophen and acetaminophen glucuronide) in human volunteers after oral intake of a single dose (1000 mg) of acetaminophen. </plain></SENT>
<SENT sid="5" pm="."><plain>The TaqMan SNP genotyping assay was used for UGT1A1 genotyping. </plain></SENT>
<SENT sid="6" pm="."><plain>The wild-type genotype (C/C) was observed the most frequent one for both SNPs (rs8330 and rs10929303) and associated with fast glucuronidator phenotypes. </plain></SENT>
<SENT sid="7" pm="."><plain>The distribution of variant genotype (G/G) for SNP rs8330 was observed in 5% of male and 8% of the female population; however, for SNP rs10929303, the G/G genotype was found in 8% of both genders. </plain></SENT>
<SENT sid="8" pm="."><plain>A trimodal distribution (fast, intermediate, and slow) based on phenotypes was observed. </plain></SENT>
<SENT sid="9" pm="."><plain>Among the male participants, the glucuronidation phenotypes were observed as 7% slow, 37% intermediate, and 56% fast glucuronidators; however, these findings for the females were slightly different as 8%, 32%, and 60% respectively. </plain></SENT>
<SENT sid="10" pm="."><plain>The k-statistics revealed a compelling evidence for good concordance between phenotype and genotype with a k value of 1.00 for SNP rs8330 and 0.966 for SNP rs10929303 in our population. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>acetaminophen glucuronide</kwd><kwd>APAP</kwd><kwd>bilirubin</kwd><kwd>HPLC</kwd><kwd>Pakistan</kwd><kwd>paracetamol</kwd><kwd>UGT</kwd><kwd>UGT1A1</kwd></kwd-group></SecTag><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>July-September 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><SecTag type="INTRO"><sec sec-type="intro" id="section1-1559325817723731"><title><text><SENT sid="11" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="12" pm="."><plain>The drug-metabolizing enzymes are responsible for biotransformation and final excretion of xenobiotics and drugs by increasing their hydrophilicity. </plain></SENT>
<SENT sid="13" pm="."><plain>Biotransformation of drugs involved the cytochrome P450-based phase I reactions (oxidation, reduction, and hydrolysis) and phase II reactions. </plain></SENT>
<SENT sid="14" pm="."><plain>In phase II of drug metabolism, there are conjugation actions like glucuronidation by uridine diphosphate (UDP) glucuronosyltransferases (UGTs), acetylation by N-acetyltransferase (NAT), and glutathione-S-transferase in the liver, with numerous proteins accountable for transportation. </plain></SENT>
<SENT sid="15" pm="."><plain>The enzymes involved in both phases are highly polymorphic. </plain></SENT>
<SENT sid="16" pm="."><plain>Interindividual variability exists in the comparative extent of phase I and II enzyme activities that influence biological responses to drug and xenobiotic exposure.1,2 </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>The UGT (EC 2.4.1.17) is a microsomal enzyme existing in almost all living beings such as bacteria, animals, plants, and humans. </plain></SENT>
<SENT sid="18" pm="."><plain>The UGT is responsible for the glucuronidation of several exogenous compounds and drugs from almost all therapeutic classes and endogenous bilirubin. </plain></SENT>
<SENT sid="19" pm="."><plain>Glucuronidation accounts for 40% to 70% of xenobiotic elimination approximately. </plain></SENT>
<SENT sid="20" pm="."><plain>Through glucuronidation, small lipophilic molecules got conjugated with UDP and more water-soluble molecules are formed.3 The removal of a broad range of xenobiotics as a consequence of UGT-mediated conjugation explains the drug detoxifying and transformation potential of this enzyme.3,4 </plain></SENT>
</text></p><p><text><SENT sid="21" pm="."><plain>Acetaminophen (acetyl-para-aminophenol [APAP]/paracetamol) is an extensively used analgesic over-the-counter drug. </plain></SENT>
<SENT sid="22" pm="."><plain>The APAP biotransformation is based on its conjugation with glucuronic acid catalyzed by UGT. </plain></SENT>
<SENT sid="23" pm="."><plain>This conjugation reaction results in a more water-soluble APAP molecule by shifting the glucuronosyl moiety from UDP-glucuronic acid to acetaminophen. </plain></SENT>
<SENT sid="24" pm="."><plain>As the glucuronidation is a major metabolic pathway of APAP, the acetaminophen glucuronide is the primary drug metabolite that can be identified in the blood.5 </plain></SENT>
</text></p><p><text><SENT sid="25" pm="."><plain>The glucuronidation activity studied among different ethnic groups is well differentiated as a bimodal and a trimodal distribution. </plain></SENT>
<SENT sid="26" pm="."><plain>Based on the glucuronidation status, the individuals among a population may be categorized as fast and slow glucuronidators (bimodal model)6 or as fast, intermediate, and slow glucuronidators (trimodal model).7,8 The slow glucuronidation phenotype is widespread in Yorubans (50%), Caucasians (23%), and Japanese (16%). </plain></SENT>
<SENT sid="27" pm="."><plain>The fraction of fast and slow glucuronidators varies among different ethnic divisions.9 </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>The superfamily UGT is divided into 4 subfamilies on account of amino acid sequence homology, named UDP-glucuronosyltransferase 1, 2, 3, and 4. </plain></SENT>
<SENT sid="29" pm="."><plain>The isozymes of family UGT1A have the first exon that is spliced into 2 to 5 common exons and thus producing a C and N-terminal domain. </plain></SENT>
<SENT sid="30" pm="."><plain>The gene-specific promoter region is possessed by each member of UGT1A family.10 In human, 13 isoenzymes from UGT1A gene, located on chromosome 2q37, are known to be originated as a consequence of a genetic alteration in exon 1 region; however, 6 isoforms of the UGTB2 subfamily are encoded by a rigid cluster of separate genes located on chromosome 4.11 </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>Both UGT1A and UGT2B genes are highly polymorphic. </plain></SENT>
<SENT sid="32" pm="."><plain>Polymorphisms of UGT1A1 gene are known to be associated with variation in glucuronidation status and consequently with the susceptibility of a number of diseases. </plain></SENT>
<SENT sid="33" pm="."><plain>Commonly, a single nucleotide polymorphism (SNP) in UGT1A1 results in a reduced expression and enzyme activity of UGT that predispose to a clinical condition known as jaundice observed in Crigler-Najjar syndrome, type 1 and type 2.12 Interindividual variability in acetaminophen glucuronidation capacity is ascribed to the polymorphism of UGT1A1 gene. </plain></SENT>
<SENT sid="34" pm="."><plain>The polymorphism UGT1A1*28 is associated with reduced glucuronidation of bilirubin by hepatic UGTs, observed in Gilbert Syndrome and also results in altered acetaminophen metabolism.13,14 </plain></SENT>
</text></p><p><text><SENT sid="35" pm="."><plain>Genotypic and phenotypic characterization of UGT1A1 among healthy population may endorse the emerging concept of “Precision Medicine” based on the valuable information regarding genetic polymorphism and associated individuals’ capacity of glucuronidation. </plain></SENT>
<SENT sid="36" pm="."><plain>In the present study, the effect of UGT1A polymorphism (rs8330 and rs10929303) was studied on glucuronidation status of acetaminophen among local healthy male and female volunteers. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="section2-1559325817723731"><title><text><SENT sid="37" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><p><text><SENT sid="38" pm="."><plain>The study was approved by the institutional ethics committee and written informed consent was taken from each volunteer. </plain></SENT>
<SENT sid="39" pm="."><plain>The volunteers were asked to maintain an overnight fasting and then blood sample (3 mL through venepuncture) was collected before and after 1.5 hours of oral administration of a single dose of acetaminophen (Panadol, 1000 mg). </plain></SENT>
<SENT sid="40" pm="."><plain>The blood samples were processed for cell-free plasma (centrifuged at 5000 rpm for 10 minutes) and stored at −20°C till further analysis. </plain></SENT>
</text></p><sec id="section3-1559325817723731"><title><text><SENT sid="41" pm="."><plain>Study Population </plain></SENT>
</text></title><p><text><SENT sid="42" pm="."><plain>A total number of 109 human volunteers (Pakistani nationals) were enrolled including 59 males (54.13%) and 50 females (45.87%), with an average age of around 22 years. </plain></SENT>
<SENT sid="43" pm="."><plain>The demographic data are given in Table 1. </plain></SENT>
<SENT sid="44" pm="."><plain>The baseline clinical examination and lab studies were performed to ensure the normal health status of all study participants. </plain></SENT>
<SENT sid="45" pm="."><plain>The volunteers were allowed to have a normal diet and alcohol, coffee and other caffeinated drinks were prohibited. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="table1-1559325817723731" orientation="portrait" position="float"><label>Table 1.</label><caption><p><text><SENT sid="46" pm="."><plain>Comparative Demographic Data of Healthy Male and Female Participants. </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table1"/><table frame="hsides" rules="groups"><thead><tr><th colspan="2" rowspan="2"><text><SENT sid="47" pm="."><plain>Parameters </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="48" pm="."><plain>Male (n = 59) </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="49" pm="."><plain>Female (n = 50) </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>Mean (±) SD </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>Min </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>Max </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>Mean ± SD </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>Min </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>Max </plain></SENT>
</text></th></tr></thead><tbody><tr><td colspan="2" rowspan="1"><text><SENT sid="56" pm="."><plain>Age (years) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>22.2 (2.4) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>19 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>22.3 (2.4) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>18 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>29 </plain></SENT>
</text></td></tr><tr><td colspan="2" rowspan="1"><text><SENT sid="63" pm="."><plain>Weight (kg) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>69.8 (10.5) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>46 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>102 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>55.8 (9.4) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>40 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>80 </plain></SENT>
</text></td></tr><tr><td colspan="2" rowspan="1"><text><SENT sid="70" pm="."><plain>Height (cm) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>170.9 (7.9) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>154.9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>187.9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>160.2 (4.4) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>144.8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>170.2 </plain></SENT>
</text></td></tr><tr><td colspan="2" rowspan="1"><text><SENT sid="77" pm="."><plain>Body temp (°F) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>98.2 (0.3) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>98 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>98.6 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>98.2 (0.4) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>98.2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>98.6 </plain></SENT>
</text></td></tr><tr><td rowspan="2" colspan="1"><text><SENT sid="84" pm="."><plain>Blood pressure (mm Hg) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>Systolic </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>116.8 (4.7) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>110 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>120 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>115.8 (5.8) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>100 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>130 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>Diastolic </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>77.5 (5.1) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>70 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>90 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>80 (7.3) </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>70 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>90 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-1559325817723731"><p><text><SENT sid="99" pm="."><plain>Abbreviations: Min, minimum; Max, maximum; SD, standard deviation; n, number of participants. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="section4-1559325817723731"><title><text><SENT sid="100" pm="."><plain>Exclusion Criteria </plain></SENT>
</text></title><p><text><SENT sid="101" pm="."><plain>Individuals having a history of any allergic response to nonsteroidal anti-inflammatory drugs including acetaminophen and any clinical illness such as diabetes, hepatitis, hypertension, and/or pregnancy were excluded. </plain></SENT>
</text></p></sec><sec id="section5-1559325817723731"><title><text><SENT sid="102" pm="."><plain>Chemicals and Reagents </plain></SENT>
</text></title><p><text><SENT sid="103" pm="."><plain>The reference standard of acetaminophen (purity &gt;99.0%) and acetaminophen β-d-glucuronide (analytical standard) were purchased from Sigma-Aldrich, St. Louis, Missouri, USA. </plain></SENT>
<SENT sid="104" pm="."><plain>Acetaminophen (Panadol) manufactured by Pharmatec Pvt Ltd (Pakistan) was purchased from the market. </plain></SENT>
<SENT sid="105" pm="."><plain>All the solvents and chemicals used were HPLC grade with high purity. </plain></SENT>
<SENT sid="106" pm="."><plain>Genomic DNA isolation kit was purchased from Biobasic Inc, Amherst, New York, USA and the RedSafe™ staining solution and TaqMan probes from Applied Biosystems, Foster City, California, USA. </plain></SENT>
<SENT sid="107" pm="."><plain>Deionized distilled water was obtained from Central High Tech Lab (Advanced GS-590, Distillery, and CPW-200 Japan), University of Agriculture, Faisalabad. </plain></SENT>
<SENT sid="108" pm="."><plain>Drug-free plasma was obtained from Chiniot Dialysis Centre, Faisalabad. </plain></SENT>
</text></p></sec><sec id="section6-1559325817723731"><title><text><SENT sid="109" pm="."><plain>Determination of Acetaminophen Glucuronidation (Phenotype) </plain></SENT>
</text></title><p><text><SENT sid="110" pm="."><plain>The UGT1A1 activity was evaluated with HPLC-based modified Vertzoni et al15 method measuring the glucuronidation status of the acetaminophen used as a probe drug. </plain></SENT>
</text></p><p><text><SENT sid="111" pm="."><plain>Frozen blood specimen was thawed prior further processing for HPLC analysis for plasma acetaminophen and acetaminophen glucuronide. </plain></SENT>
<SENT sid="112" pm="."><plain>The deproteinization was achieved through mixing 100 µL plasma (of each specimen) with 200 µL of perchloric acid (15%) followed by vortex mixing for 1 minute and finally centrifuged at 13,000 rpm (16 110 × g) for 10 minutes. </plain></SENT>
<SENT sid="113" pm="."><plain>The supernatant was filtered through syringe filters (0.22 µm). </plain></SENT>
<SENT sid="114" pm="."><plain>The 20 µL of deproteinized ultrafiltrate was injected into HPLC column [Hypersil BDS-C18, 250 mm × 4.6 mm, internal diameter 5 µm (Thermo Electron Corporation, Waltham, MA, USA). </plain></SENT>
<SENT sid="115" pm="."><plain>The elution was achieved using a mobile phase constituted by aqueous buffer solution of 0.05 M KH2PO4 (475 mL), 5% acetic acid (pH 6.5), and methanol (25 mL) on isocratic mode at a flow rate of 1 mL/min. </plain></SENT>
</text></p><p><text><SENT sid="116" pm="."><plain>The method employed was found to be highly reliable and sensitive and the lower limit of quantification for acetaminophen was 2.5 µg/mL and for acetaminophen glucuronide, it was 1 µg/mL. </plain></SENT>
<SENT sid="117" pm="."><plain>The calibration curve was constructed based on 6 standard concentrations, and a good linearity was observed at the concentration range of 2.5 to 200 µg/mL (R 2 ≥0.9949 for APAP and R 2 &gt;0.9908 for APAP-Glu). </plain></SENT>
<SENT sid="118" pm="."><plain>The glucuronidation status was determined on the basis of the metabolic ratio of plasma acetaminophen glucuronide to acetaminophen (APAP-Glu/APAP), and cut-off values were identified through the probit plot. </plain></SENT>
</text></p></sec><sec id="section7-1559325817723731"><title><text><SENT sid="119" pm="."><plain>Determination of UGT1A1 Polymorphism </plain></SENT>
</text></title><sec id="section8-1559325817723731"><title><text><SENT sid="120" pm="."><plain>Isolation of genomic DNA </plain></SENT>
</text></title><p><text><SENT sid="121" pm="."><plain>The genomic DNA was isolated from venous blood previously stored at −20°C immediately after drawn from volunteers in EDTA anticoagulated tubes (BD Vacutainer®) using genomic DNA isolation kit (EZ-10 Spin Column for Genomic DNA Minipreps) manufactured by Bio-Basic Inc, Amherst, New York, USA. </plain></SENT>
<SENT sid="122" pm="."><plain>Isolated DNA was quantified on Gen5™, run on agarose gel electrophoresis (1% w/v) stained with RedSafe staining solution and documented under ultraviolet light in gel documentation system. </plain></SENT>
<SENT sid="123" pm="."><plain>High-quality DNA samples obtained were stored at −40°C for further analysis. </plain></SENT>
</text></p></sec><sec id="section9-1559325817723731"><title><text><SENT sid="124" pm="."><plain>TaqMan SNP genotyping assay for UGT1A1 gene polymorphism </plain></SENT>
</text></title><p><text><SENT sid="125" pm="."><plain>SNPs (rs10929303, c.1813C&gt;T; rs8330, c.2042C&gt;G) of the UGT1A1 gene in 3′ untranslated region (3′UTR) was studied by using sequence-specific TaqMan probes by real-time PCR (ViiA™ 7 System with Interchangeable block [96- and 384-well plate], OptiFlex™ System) manufactured by Applied Biosystem, USA. </plain></SENT>
<SENT sid="126" pm="."><plain>Oligonucleotide probes containing fluorescein amidite and VIC fluorescent dyes were used for UGT1A1 gene polymorphisms. </plain></SENT>
<SENT sid="127" pm="."><plain>Following the qPCR, the results were interpreted by allele discrimination plots (Figures 1 and 2) using ViiA 7™ Software, Applied Biosystem. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="fig1-1559325817723731" orientation="portrait" position="float"><label>Figure 1.</label><caption><p><text><SENT sid="128" pm="."><plain>Allele discrimination plot showing alleles as wild-type homozygous C/C (lower right cluster), mutant heterozygous allele C/T (middle cluster), and mutant homozygous T/T (upper right cluster) for the SNP rs10929303 by TaqMan SNP genotyping assay using ViiA 7™ Software, Applied Biosystem, USA. </plain></SENT>
<SENT sid="129" pm="."><plain>SNP indicates single nucleotide polymorphism. </plain></SENT>
</text></p></caption><graphic xlink:href="10.1177_1559325817723731-fig1"/></fig></SecTag><SecTag type="FIG"><fig id="fig2-1559325817723731" orientation="portrait" position="float"><label>Figure 2.</label><caption><p><text><SENT sid="130" pm="."><plain>Allele discrimination plot showing alleles as wild-type homozygous C/C (lower right cluster), mutant heterozygous C/G (middle cluster), and mutant homozygous G/G (upper left) for the SNP rs8330 by TaqMan SNP genotyping assay using ViiA 7™ Software, Applied Biosystem, USA. </plain></SENT>
<SENT sid="131" pm="."><plain>SNP indicates single nucleotide polymorphism. </plain></SENT>
</text></p></caption><graphic xlink:href="10.1177_1559325817723731-fig2"/></fig></SecTag><p><text><SENT sid="132" pm="."><plain>The DNA template (40 ng) was added in 384-well plate for drying prior to the addition of an optimized reaction mixture (5.0 µL) consisting of TaqMan genotyping master mix 2X (2.50 µL), TaqMan genotyping assay mix 20X (0.25 µL), and nucleases-free water (2.25 µL). </plain></SENT>
</text></p><p><text><SENT sid="133" pm="."><plain>The PCR conditions optimized for qPCR consisted of a preread stage of 30 seconds at 60°C, a hold stage of 10 minutes at 95°C, PCR stage including denaturation at 95°C for 15 seconds, and annealing and amplification at 62°C and 72°C for 1 minute, respectively. </plain></SENT>
</text></p></sec></sec></sec></SecTag><SecTag type="METHODS"><sec id="section10-1559325817723731"><title><text><SENT sid="134" pm="."><plain>Statistical Analysis </plain></SENT>
</text></title><p><text><SENT sid="135" pm="."><plain>The genotype and allelic frequencies were calculated using the Hardy-Weinberg equilibrium and presented in percentages. </plain></SENT>
<SENT sid="136" pm="."><plain>The frequency distribution histograms were formed using Minitab 15. </plain></SENT>
<SENT sid="137" pm="."><plain>The probit plot was used for the distribution of acetaminophen glucuronidation phenotype into fast, intermediate, and slow glucuronidators. </plain></SENT>
<SENT sid="138" pm="."><plain>K-statistics (κ test) was applied to measure the degree of agreement (concordance) between phenotype and genotype using SPSS Statistics (version 17). </plain></SENT>
<SENT sid="139" pm="."><plain>The comparison of parameters between male and female volunteers was evaluated by chi-square test. </plain></SENT>
</text></p></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="section11-1559325817723731"><title><text><SENT sid="140" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="141" pm="."><plain>The glucuronidation status of UGT1A1 was determined in healthy male (n = 59) and female (n = 50) participants after a single oral dose of 1000 mg acetaminophen. </plain></SENT>
<SENT sid="142" pm="."><plain>The concentration of acetaminophen and acetaminophen glucuronide was measured in blood samples drawn at 1.5-hours following of its oral intake. </plain></SENT>
<SENT sid="143" pm="."><plain>The APAP-Glu/APAP metabolic ratio for the male volunteers ranged from 0.23 to 4.72, and 81% male volunteers have a metabolic ratio ranging from 0.2 to 2.8. </plain></SENT>
<SENT sid="144" pm="."><plain>The allocation of glucuronidation phenotype illustrated that 7% (n = 4) were slow, 37% (n = 22) were intermediate, and 56% (n = 33) male volunteers were fast glucuronidators phenotypically whereas in female population the APAP-Glu/APAP metabolic ratio ranged from 0.26 to 2.95, and 82% of female volunteers have metabolic ratio ranging from 0.6 to 1.8. </plain></SENT>
<SENT sid="145" pm="."><plain>The distribution of slow, intermediate, and fast glucuronidators among females was 8% (n = 4), 32% (n = 16), and 60% (n = 30), respectively. </plain></SENT>
<SENT sid="146" pm="."><plain>The frequency histograms of APAP-Glu/APAP metabolic ratio of male and female volunteers are shown in Figures 3 and 4, respectively. </plain></SENT>
<SENT sid="147" pm="."><plain>The volunteers who had a metabolic ratio less than or equal to 0.3 were found to be slow glucuronidators whereas those with a metabolic ratio of &gt;0.3 were intermediate glucuronidators. </plain></SENT>
<SENT sid="148" pm="."><plain>The fast or rapid glucuronidators phenotypes were assigned to the volunteers with a metabolic ratio of ≥1.8. </plain></SENT>
<SENT sid="149" pm="."><plain>The cut-off points of metabolic ratios for discriminating the phenotypes were identified from probit plot as shown in Figure 5. </plain></SENT>
<SENT sid="150" pm="."><plain>The probit plot provides the information regarding how closely the data points follow the fitted distribution line. </plain></SENT>
<SENT sid="151" pm="."><plain>The distribution of glucuronidation phenotype was found a good fit, as the points fall closely along the straight lines. </plain></SENT>
<SENT sid="152" pm="."><plain>For a normal distribution achieved with APAP-Glu/APAP ratio, around 8% population has been observed to have slow glucuronidation phenotype. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="fig3-1559325817723731" orientation="portrait" position="float"><label>Figure 3.</label><caption><p><text><SENT sid="153" pm="."><plain>Frequency histogram of the metabolic ratio of APAP-Glu/APAP showing trimodal distribution (slow, intermediate, and fast) of healthy male volunteers (n = 59). </plain></SENT>
<SENT sid="154" pm="."><plain>APAP-Glu indicates acetyl-para-aminophenol-glucuronide. </plain></SENT>
</text></p></caption><graphic xlink:href="10.1177_1559325817723731-fig3"/></fig></SecTag><SecTag type="FIG"><fig id="fig4-1559325817723731" orientation="portrait" position="float"><label>Figure 4.</label><caption><p><text><SENT sid="155" pm="."><plain>Frequency histogram of the metabolic ratio of APAP-Glu/APAP showing trimodal distribution (slow, intermediate, and fast) of healthy female volunteers (n = 50). </plain></SENT>
<SENT sid="156" pm="."><plain>APAP-Glu indicates acetyl-para-aminophenol-glucuronide. </plain></SENT>
</text></p></caption><graphic xlink:href="10.1177_1559325817723731-fig4"/></fig></SecTag><SecTag type="FIG"><fig id="fig5-1559325817723731" orientation="portrait" position="float"><label>Figure 5.</label><caption><p><text><SENT sid="157" pm="."><plain>Probability plot of acetaminophen glucuronide/acetaminophen metabolic ratio in healthy male and female volunteers (n = 109) showing cut-off points for distribution of fast, intermediate, and slow glucuronidation phenotype. </plain></SENT>
</text></p></caption><graphic xlink:href="10.1177_1559325817723731-fig5"/></fig></SecTag><p><text><SENT sid="158" pm="."><plain>A total of 109 human volunteers (male = 59, female = 50) were genotyped in this study. </plain></SENT>
<SENT sid="159" pm="."><plain>Two SNPs (rs10929303, rs8330) were studied in 3′ untranslated region of UGT1A1 gene. </plain></SENT>
<SENT sid="160" pm="."><plain>Mutant alleles for SNPs, rs10929303 and rs8330, were identified as alleles having a substitution at the positions of nucleotides, 1813 and 2042, respectively. </plain></SENT>
<SENT sid="161" pm="."><plain>In our study, the major genotypes for SNP (rs8330) are C/C &amp; C/G and for SNP (rs10929303) are C/C &amp; C/T, respectively, in both male and female. </plain></SENT>
<SENT sid="162" pm="."><plain>The frequency distribution of homozygous wild-type, heterozygous and homozygous mutant alleles, and the genotype frequency for both SNPs are summarized in Table 2. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="table2-1559325817723731" orientation="portrait" position="float"><label>Table 2.</label><caption><p><text><SENT sid="163" pm="."><plain>Allele and Genotype Frequency Distribution of UGT1A1 (rs8330 and rs10929303) in Healthy Volunteers. </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table2"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="164" pm="."><plain>UGT1A1 Polymorphisms </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="165" pm="."><plain>Genotypes </plain></SENT>
</text></th><th colspan="2" rowspan="1"><text><SENT sid="166" pm="."><plain>Genotype Frequency </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="167" pm="."><plain>Alleles </plain></SENT>
</text></th><th colspan="2" rowspan="1"><text><SENT sid="168" pm="."><plain>Allelic Frequency </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>Male (%) </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>Female (%) </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>Male (%) </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>Female (%) </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="3" colspan="1"><text><SENT sid="173" pm="."><plain>rs8330 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>C/C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>54.23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>60 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="178" pm="."><plain>73.7 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="179" pm="."><plain>75.5 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="180" pm="."><plain>C/G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="181" pm="."><plain>40.68 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="182" pm="."><plain>32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text></text></td><td rowspan="1" colspan="1"><text></text></td><td rowspan="1" colspan="1"><text></text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="183" pm="."><plain>G/G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="184" pm="."><plain>5.08 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="185" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="186" pm="."><plain>G </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="187" pm="."><plain>26.2 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="188" pm="."><plain>24.4 </plain></SENT>
</text></td></tr><tr><td rowspan="3" colspan="1"><text><SENT sid="189" pm="."><plain>rs10929303 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="190" pm="."><plain>C/C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="191" pm="."><plain>52.54 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="192" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="193" pm="."><plain>C </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="194" pm="."><plain>72 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="195" pm="."><plain>75.5 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="196" pm="."><plain>C/T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="197" pm="."><plain>38.98 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="198" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text></text></td><td rowspan="1" colspan="1"><text></text></td><td rowspan="1" colspan="1"><text></text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="199" pm="."><plain>T/T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="200" pm="."><plain>8.47 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="201" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="202" pm="."><plain>T </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="203" pm="."><plain>27.9 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="204" pm="."><plain>24.4 </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag><p><text><SENT sid="205" pm="."><plain>The allelic frequencies of both SNPs (rs8330 and rs10929303) in male and female are in Hardy-Weinberg equilibrium. </plain></SENT>
<SENT sid="206" pm="."><plain>The genotype frequencies of UGT1A1 gene SNPs (rs8330 and rs10929303) differ insignificantly (p-value &gt; 0.05) among male and female volunteers. </plain></SENT>
</text></p><p><text><SENT sid="207" pm="."><plain>The concordance was calculated between UGT1A1 genotype and phenotype statistically. </plain></SENT>
<SENT sid="208" pm="."><plain>The k-statistics revealed an outstanding degree of association between phenotype and genotype with a κ value of 1.00 in both male and female participants for SNP rs8330 as shown in Table 3. </plain></SENT>
<SENT sid="209" pm="."><plain>The κ value also indicated good concordance between genotype (rs10929303) and phenotype (κ = 0.966) as shown in Table 4. </plain></SENT>
<SENT sid="210" pm="."><plain>No association of specific glucuronidator phenotypes was found between male and female volunteers (χ2 = 0.582; P = 0.748). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="table3-1559325817723731" orientation="portrait" position="float"><label>Table 3.</label><caption><p><text><SENT sid="211" pm="."><plain>Comparison of Genotype (rs8330) and Acetaminophen Phenotype in Male and Female Volunteers.a </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table3"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="212" pm="."><plain>Acetaminophen Phenotype </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="213" pm="."><plain>Genotype (rs8330) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="214" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="215" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="216" pm="."><plain>C/G </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="217" pm="."><plain>G/G </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="218" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="219" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="220" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="221" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="222" pm="."><plain>62 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="223" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="224" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="225" pm="."><plain>39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="226" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="227" pm="."><plain>39 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="228" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="229" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="230" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="231" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="232" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="233" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="234" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="235" pm="."><plain>39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="236" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="237" pm="."><plain>109 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn2-1559325817723731"><p><text><SENT sid="238" pm="."><plain>aκ value = 1. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="table4-1559325817723731" orientation="portrait" position="float"><label>Table 4.</label><caption><p><text><SENT sid="239" pm="."><plain>Comparison of Genotype (rs10929303) and Acetaminophen Phenotype in Male and Female Volunteers.a </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table4"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="240" pm="."><plain>Acetaminophen Phenotype </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="241" pm="."><plain>Genotype (rs10929303) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="242" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="243" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="244" pm="."><plain>C/T </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="245" pm="."><plain>T/T </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="246" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="247" pm="."><plain>61 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="248" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="249" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="250" pm="."><plain>62 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="251" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="252" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="253" pm="."><plain>38 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="254" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="255" pm="."><plain>39 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="256" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="257" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="258" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="259" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="260" pm="."><plain>8 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="261" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="262" pm="."><plain>62 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="263" pm="."><plain>39 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="264" pm="."><plain>8 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="265" pm="."><plain>109 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn3-1559325817723731"><p><text><SENT sid="266" pm="."><plain>aκ value = 0.969. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><p><text><SENT sid="267" pm="."><plain>For SNP rs8330, the frequency distribution data of slow and intermediate glucuronidator phenotypes and the associated genotypes for male and female volunteers are given in Tables 5 and 6, respectively. </plain></SENT>
<SENT sid="268" pm="."><plain>The comparative data of genotypes for SNP rs10929303 and associated glucuronidator phenotypes in male and female volunteers are shown in Tables 7 and 8, respectively. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="table5-1559325817723731" orientation="portrait" position="float"><label>Table 5.</label><caption><p><text><SENT sid="269" pm="."><plain>Comparison of Acetaminophen Phenotype/UGT1A1 (rs8330) Genotype in Male Volunteers.a,b </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table5"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="270" pm="."><plain>Acetaminophen Phenotype (Male) </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="271" pm="."><plain>Genotype rs8330 (Male) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="272" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="273" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="274" pm="."><plain>C/G </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="275" pm="."><plain>G/G </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="276" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="277" pm="."><plain>32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="278" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="279" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="280" pm="."><plain>32 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="281" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="282" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="283" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="284" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="285" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="286" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="287" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="288" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="289" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="290" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="291" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="292" pm="."><plain>32 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="293" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="294" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="295" pm="."><plain>59 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn4-1559325817723731"><p><text><SENT sid="296" pm="."><plain>an = 59. </plain></SENT>
</text></p></fn><fn id="table-fn5-1559325817723731"><p><text><SENT sid="297" pm="."><plain>bκ value = 1. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="table6-1559325817723731" orientation="portrait" position="float"><label>Table 6.</label><caption><p><text><SENT sid="298" pm="."><plain>Comparison of Acetaminophen Phenotype/UGT1A1 rs8330 Genotype in Female Volunteers.a,b </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table6"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="299" pm="."><plain>Acetaminophen Phenotype (Female) </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="300" pm="."><plain>Genotype rs8330 (Female) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="301" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="302" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="303" pm="."><plain>C/G </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="304" pm="."><plain>G/G </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="305" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="306" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="307" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="308" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="309" pm="."><plain>30 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="310" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="311" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="312" pm="."><plain>16 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="313" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="314" pm="."><plain>16 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="315" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="316" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="317" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="318" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="319" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="320" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="321" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="322" pm="."><plain>16 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="323" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="324" pm="."><plain>50 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn6-1559325817723731"><p><text><SENT sid="325" pm="."><plain>an = 50. </plain></SENT>
</text></p></fn><fn id="table-fn7-1559325817723731"><p><text><SENT sid="326" pm="."><plain>bκ value = 1. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="table7-1559325817723731" orientation="portrait" position="float"><label>Table 7.</label><caption><p><text><SENT sid="327" pm="."><plain>Comparison of Acetaminophen Phenotype/UGT1A1 (rs10929303) Genotype in Male Volunteers.a </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table7"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="328" pm="."><plain>Acetaminophen Phenotype (Male) </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="329" pm="."><plain>Genotype rs10929303 (Male) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="330" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="331" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="332" pm="."><plain>C/T </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="333" pm="."><plain>T/T </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="334" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="335" pm="."><plain>31 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="336" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="337" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="338" pm="."><plain>32 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="339" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="340" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="341" pm="."><plain>23 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="342" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="343" pm="."><plain>23 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="344" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="345" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="346" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="347" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="348" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="349" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="350" pm="."><plain>31 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="351" pm="."><plain>24 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="352" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="353" pm="."><plain>59 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn8-1559325817723731"><p><text><SENT sid="354" pm="."><plain>aκ value = 0.969. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="table8-1559325817723731" orientation="portrait" position="float"><label>Table 8.</label><caption><p><text><SENT sid="355" pm="."><plain>Comparison of Acetaminophen Phenotype/UGT1A1 (rs10929303) Genotype in Female Volunteers.a,b </plain></SENT>
</text></p></caption><alternatives><graphic xlink:href="10.1177_1559325817723731-table8"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"><text><SENT sid="356" pm="."><plain>Acetaminophen Phenotype (Female) </plain></SENT>
</text></th><th colspan="3" rowspan="1"><text><SENT sid="357" pm="."><plain>Genotype rs10929303 (Female) </plain></SENT>
</text></th><th rowspan="2" colspan="1"><text><SENT sid="358" pm="."><plain>Total </plain></SENT>
</text></th></tr><tr><th rowspan="1" colspan="1"><text><SENT sid="359" pm="."><plain>C/C </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="360" pm="."><plain>C/T </plain></SENT>
</text></th><th rowspan="1" colspan="1"><text><SENT sid="361" pm="."><plain>T/T </plain></SENT>
</text></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><text><SENT sid="362" pm="."><plain>Fast </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="363" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="364" pm="."><plain>1 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="365" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="366" pm="."><plain>31 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="367" pm="."><plain>Intermediate </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="368" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="369" pm="."><plain>15 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="370" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="371" pm="."><plain>15 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="372" pm="."><plain>Slow </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="373" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="374" pm="."><plain>0 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="375" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="376" pm="."><plain>4 </plain></SENT>
</text></td></tr><tr><td rowspan="1" colspan="1"><text><SENT sid="377" pm="."><plain>Total </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="378" pm="."><plain>30 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="379" pm="."><plain>16 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="380" pm="."><plain>4 </plain></SENT>
</text></td><td rowspan="1" colspan="1"><text><SENT sid="381" pm="."><plain>50 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn9-1559325817723731"><p><text><SENT sid="382" pm="."><plain>an = 50. </plain></SENT>
</text></p></fn><fn id="table-fn10-1559325817723731"><p><text><SENT sid="383" pm="."><plain>bκ value = 1. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="discussion" id="section12-1559325817723731"><title><text><SENT sid="384" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="385" pm="."><plain>Interindividual differences in activity of drug metabolizing enzymes have been associated with the personalized responsiveness to the toxicants and drugs in a population. </plain></SENT>
<SENT sid="386" pm="."><plain>Glucuronidation is the best launched example of polymorphism in the drug metabolizing enzyme.16 </plain></SENT>
</text></p><p><text><SENT sid="387" pm="."><plain>A pathologically reduced UGT enzyme activity has been ascribed to the genetic polymorphism of UGT1A gene family, attributed to an altered transcriptional pattern and function of the resultant protein. </plain></SENT>
<SENT sid="388" pm="."><plain>The mutant alleles of UGT1A1 gene result in declined bilirubin conjugation capacity of UGT1A1 isoform. </plain></SENT>
<SENT sid="389" pm="."><plain>The UGT1A gene polymorphism also contributes to the individual’s susceptibility to various diseases owing to the altered process of inactivation and detoxification of xenobiotics and carcinogens.17 </plain></SENT>
</text></p><p><text><SENT sid="390" pm="."><plain>Kadakol et al18 summarized the data of approximately 50 polymorphisms of UGT1A1 gene contributing to Crigler-Najjar syndrome type I and II. </plain></SENT>
<SENT sid="391" pm="."><plain>The type I syndrome is a clinical condition presented with nonhemolytic jaundice, characterized by marked unconjugated hyperbilirubinemia and frequent central nervous system involvement because of no UGT1A1 activity. </plain></SENT>
<SENT sid="392" pm="."><plain>Another condition associated with UGT1A1 enzyme inactivity is Gilbert syndrome associated with a polymorphism in the promoter region of UGT1A1 gene.19 The differential expression and function of the UGT1A isoforms in the colon,20 liver,21 pancreas,22 and kidney cancers23 have been reported. </plain></SENT>
</text></p><p><text><SENT sid="393" pm="."><plain>A higher risk of having colorectal carcinoma is reported among individuals carrying mutant alleles of UGT1A gene.24 The breast cancer susceptibility is also found to be associated with mutant however, no relationship has been observed yet between estrogen receptor status and the UGT1A1 genotypes.25,26 </plain></SENT>
</text></p><p><text><SENT sid="394" pm="."><plain>Acetaminophen glucuronide is a major conjugate formed during acetaminophen biotransformation among conjugates of sulfate, cysteine, and mercapturate as reported by Pabba et al27 in healthy Indian population. </plain></SENT>
</text></p><p><text><SENT sid="395" pm="."><plain>In our research, the genetic polymorphism of UGT1A (rs8330 and rs10929303) in local population has been studied and reported for the first time in Pakistan. </plain></SENT>
<SENT sid="396" pm="."><plain>No authentic study has been accessed through standard databases and search engines with the focus of UGT1A1 genotypes being reported here (rs8330 and rs10929303) and their effect on the phenotypic distribution for Pakistani population. </plain></SENT>
</text></p><p><text><SENT sid="397" pm="."><plain>The major aim of the research was to study the association or concordance between UGT1A1 genotype and glucuronidation phenotype. </plain></SENT>
<SENT sid="398" pm="."><plain>Our results showed a good association between UGT1A1 genotype for both SNPs (rs8330 and rs10929303) and capacity of acetaminophen glucuronidation in healthy volunteers. </plain></SENT>
</text></p><p><text><SENT sid="399" pm="."><plain>The HPLC-based phenotypic studies for acetaminophen glucuronidation have been conducted in Hong Kong, Chinese, and Caucasian healthy population using acetaminophen as probe drug.28,29 </plain></SENT>
</text></p><p><text><SENT sid="400" pm="."><plain>Based on the individuals’ glucuronidation ability, accessed by plasma PAP-Glu/PAP ratio, the studied populations have presented a trimodal phenotypic distribution and the volunteers have been classified as fast, intermediate, and slow glucuronidators. </plain></SENT>
<SENT sid="401" pm="."><plain>The similar approach of phenotypic characterization of UGT1A1 through the ratio of morphine-glucuronide/morphine ratio, using morphine as probe drug, was reported by Holthe et al.8 </plain></SENT>
</text></p><p><text><SENT sid="402" pm="."><plain>In the present study, a comparable distribution of slow glucuronidator phenotype was observed between healthy male (7%) and female (8%) volunteers. </plain></SENT>
<SENT sid="403" pm="."><plain>The phenotypic distribution of intermediate and fast glucuronidators slightly differ among male and female volunteers. </plain></SENT>
<SENT sid="404" pm="."><plain>The volunteers with intermediate glucuronidator phenotype were 37% among males and 32% among females. </plain></SENT>
<SENT sid="405" pm="."><plain>There is a slightly higher percentage of female fast glucuronidators, that is, 60% versus 56% of male volunteers. </plain></SENT>
<SENT sid="406" pm="."><plain>However, on the basis of urine and saliva samples from healthy volunteers, a higher glucuronidation status have been reported among male participants as compared to the females.30 These noncomparable results of glucuronidation might be associated with the relative bioavailability, excretion, and elimination of acetaminophen in blood, saliva, and urine respectively. </plain></SENT>
</text></p><p><text><SENT sid="407" pm="."><plain>Moreover, the divergent research findings among populations may be attributed to the ethnic differences owing to the particular genetic make-up of different populations. </plain></SENT>
<SENT sid="408" pm="."><plain>Besides pharmacogenetics, the geographical basis, environmental aspects, and diet (ie, differences in protein intake) may also contribute to the ethnic diversity of acetaminophen biotransformation.31 Distribution of UGT1A1 alleles (rs8330 and rs10929303) in our data shows resemblance with the Caucasian, Mexican, and Tuscan population.9 </plain></SENT>
</text></p><p><text><SENT sid="409" pm="."><plain>Conclusively, through our study, the UGT1A1 phenotypes encoded by wild-type alleles (C/C) for both SNPs (rs8330 and rs10929303) are categorized as fast glucuronidator based on their plasma acetaminophen glucuronidation status. </plain></SENT>
<SENT sid="410" pm="."><plain>Participants with mutant homozygous alleles for both SNPs (G/G, T/T, for rs8330 and rs10929303, respectively) were found to have slow glucuronidator phenotype. </plain></SENT>
<SENT sid="411" pm="."><plain>However, the individuals with heterozygous alleles were categorized as intermediate glucuronidators. </plain></SENT>
</text></p></sec></SecTag></body><back><fn-group><fn fn-type="other" id="fn1-1559325817723731"><p><text><SENT sid="412" pm="."><plain>Authors’ Note: Huma Mehboob carried out the HPLC analysis of acetaminophen, acetaminophen glucuronide, DNA Isolation, Quantification, and RT-PCR of UGT1A1 SNPs (rs8330 and rs10929303). </plain></SENT>
<SENT sid="413" pm="."><plain>Huma Mehboob and Imtiaz Mahmood Tahir inferred the data and drafted the manuscript. </plain></SENT>
<SENT sid="414" pm="."><plain>All authors critically reviewed the manuscript before submission. </plain></SENT>
<SENT sid="415" pm="."><plain>Dr Huma Mehboob is the guarantor and principal investigator. </plain></SENT>
</text></p></fn></fn-group><SecTag type="AUTH_CONT"><ack><title>Acknowledgments</title><p>Authors highly acknowledge the Higher Education Commission, Pakistan, for providing funds for the research. For research facilities, authors duly appreciate the contribution of Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University West Lafayette, Indiana, USA, and Pharmaceutical Research Lab, Department of Biochemistry, University of Agriculture Faisalabad-Pakistan.</p></ack></SecTag><fn-group><fn fn-type="COI-statement" id="fn2-1559325817723731"><p><text><SENT sid="416" pm="."><plain>Declaration of Conflicting Interests: The author(s) declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article. </plain></SENT>
</text></p></fn><fn fn-type="financial-disclosure" id="fn3-1559325817723731"><p><text><SENT sid="417" pm="."><plain>Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research project was funded by Higher Education Commission, Islamabad, Pakistan. </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><title>References</title><ref id="bibr1-1559325817723731"><text><SENT sid="418" pm="."><plain>1 KooSHLeeEJD Pharmacogenetics approach to therapeutics. Clin Exp Pharmacol Physiol. 2006;33(5-6):525–532.16700889 </plain></SENT>
</text></ref><ref id="bibr2-1559325817723731"><text><SENT sid="419" pm="."><plain>2 TahirIMIqbalTSaleemSMehboobHAkhterNRiazM Effect of acetaminophen on sulfamethazine acetylation in male volunteers. Int J Immunopathol Pharmacol. 2016;29(1):17–22.26519524 </plain></SENT>
</text></ref><ref id="bibr3-1559325817723731"><text><SENT sid="420" pm="."><plain>3 AhnSJDermauwWWybouwN Bacterial origin of a diverse family of UDP-glycosyltransferase genes in the Tetranychus urticae genome. Insect Biochem Mol Biol. 2014;50:43–57.24727020 </plain></SENT>
</text></ref><ref id="bibr4-1559325817723731"><text><SENT sid="421" pm="."><plain>4 DesaiAAInnocentiFRatainMJ UGT pharmacogenomics. Pharmacogenetics. 2003;13(8):517–523.12893990 </plain></SENT>
</text></ref><ref id="bibr5-1559325817723731"><text><SENT sid="422" pm="."><plain>5 CourtMHFreytsisMWangX The UDP-glucuronosyltransferase (UGT) 1A polymorphism c.2042C&gt;G (rs8330) is associated with increased human liver acetaminophen glucuronidation, increased UGT1A exon 5a/5b splice variant mRNA ratio, and decreased risk of unintentional acetaminophen-induced acute liver failure. J Pharmacol Exp Ther. 2013;345(2):297–307.23408116 </plain></SENT>
</text></ref><ref id="bibr6-1559325817723731"><text><SENT sid="423" pm="."><plain>6 JakobssonJEkströmLInotsumeN Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism. J Clin Endocrinol Metab. 2006;91(2):687–693.16332934 </plain></SENT>
</text></ref><ref id="bibr7-1559325817723731"><text><SENT sid="424" pm="."><plain>7 BockKWSchrenkDForsterA The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes. Pharmacogenetics. 1994;4(4):209–218.7987405 </plain></SENT>
</text></ref><ref id="bibr8-1559325817723731"><text><SENT sid="425" pm="."><plain>8 HoltheMRakvågTNKlepstadP Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Pharmacogenomics J. 2003;3(1):17–26.12629580 </plain></SENT>
</text></ref><ref id="bibr9-1559325817723731"><text><SENT sid="426" pm="."><plain>9 ThorissonGA The international hapmap project web site. Genome Res. 2005;15(11):1592–1593.16251469 </plain></SENT>
</text></ref><ref id="bibr10-1559325817723731"><text><SENT sid="427" pm="."><plain>10 MackenziePIWalter BockKBurchellB Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics. 2005;15(10):677–685.16141793 </plain></SENT>
</text></ref><ref id="bibr11-1559325817723731"><text><SENT sid="428" pm="."><plain>11 TurgeonD Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. 2001;142(2):778–787.11159850 </plain></SENT>
</text></ref><ref id="bibr12-1559325817723731"><text><SENT sid="429" pm="."><plain>12 LiuXChengDKuangQ Association of UGT1A1* 28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians. Pharmacogenomics J. 2014;14(2):120–129.23529007 </plain></SENT>
</text></ref><ref id="bibr13-1559325817723731"><text><SENT sid="430" pm="."><plain>13 BurchellB Genetic variation of human UDP-glucuronosyltransferase. Am J Pharmacogenomics. 2003;3(1):37–52.12562215 </plain></SENT>
</text></ref><ref id="bibr14-1559325817723731"><text><SENT sid="431" pm="."><plain>14 EstebanAPérez-MateoM Heterogeneity of paracetamol metabolism in Gilbert’s syndrome. Eur J Drug Metab Pharmacokinet. 1999;24(1):9–13.10412886 </plain></SENT>
</text></ref><ref id="bibr15-1559325817723731"><text><SENT sid="432" pm="."><plain>15 VertzoniMVArchontakiHAGalanopoulouP Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of acetaminophen and its major metabolites in rabbit plasma and urine after a toxic dose. J Pharm Biomed Anal. 2003;32(3):487–493.14565553 </plain></SENT>
</text></ref><ref id="bibr16-1559325817723731"><text><SENT sid="433" pm="."><plain>16 CascorbiI Genetic basis of toxic reactions to drugs and chemicals. Toxicol Lett. 2006;162(1):16–28.16310984 </plain></SENT>
</text></ref><ref id="bibr17-1559325817723731"><text><SENT sid="434" pm="."><plain>17 GuillemetteC Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J. 2003;3(3):136–158.12815363 </plain></SENT>
</text></ref><ref id="bibr18-1559325817723731"><text><SENT sid="435" pm="."><plain>18 KadakolAGhoshSSSappalBS Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16(4):297–306.11013440 </plain></SENT>
</text></ref><ref id="bibr19-1559325817723731"><text><SENT sid="436" pm="."><plain>19 MonaghanGRyanMHumeR Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert’s syndrome. Lancet. 1996;347(9001):578–581.8596320 </plain></SENT>
</text></ref><ref id="bibr20-1559325817723731"><text><SENT sid="437" pm="."><plain>20 BiglerJWhittonJLampeJW CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res. 2001;61(9):3566–3569.11325819 </plain></SENT>
</text></ref><ref id="bibr21-1559325817723731"><text><SENT sid="438" pm="."><plain>21 TsengCSTangKSLoHW UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age. Am J Gastroenterol. 2005;100(8):1758.16086712 </plain></SENT>
</text></ref><ref id="bibr22-1559325817723731"><text><SENT sid="439" pm="."><plain>22 PiepoliA Lack of association between UGT1A7, UGT1A9, ARP, SPINK1andCFTRgene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol. 2006;12(39):6343.17072959 </plain></SENT>
</text></ref><ref id="bibr23-1559325817723731"><text><SENT sid="440" pm="."><plain>23 RouleauMRobergeJBellemareJ Dual roles for splice variants of the glucuronidation pathway as regulators of cellular metabolism. Mol Pharmacol. 2014;85(1):29–36.24141015 </plain></SENT>
</text></ref><ref id="bibr24-1559325817723731"><text><SENT sid="441" pm="."><plain>24 TangKS Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol. 2005;11(21):3250.15929176 </plain></SENT>
</text></ref><ref id="bibr25-1559325817723731"><text><SENT sid="442" pm="."><plain>25 GuillemetteCMillikanRCNewmanB Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res. 2000;60(4):950–956.10706110 </plain></SENT>
</text></ref><ref id="bibr26-1559325817723731"><text><SENT sid="443" pm="."><plain>26 AdegokeOJShuXOGaoYT Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat. 2004;85(3):239–245.15111762 </plain></SENT>
</text></ref><ref id="bibr27-1559325817723731"><text><SENT sid="444" pm="."><plain>27 PabbaSBollaSKandhagatlaR Paracetamol metabolism in Indian population. Drug Res. 2011;52(10):769–772. </plain></SENT>
</text></ref><ref id="bibr28-1559325817723731"><text><SENT sid="445" pm="."><plain>28 CritchleyJCritchleyLAndersonP Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects. J Clin Phar Ther. 2005;30(2):179–184. </plain></SENT>
</text></ref><ref id="bibr29-1559325817723731"><text><SENT sid="446" pm="."><plain>29 FlouvatBLeneveuAFitoussiS Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int J Clin Pharmacol Ther. 2004;42(1):50–57.14756388 </plain></SENT>
</text></ref><ref id="bibr30-1559325817723731"><text><SENT sid="447" pm="."><plain>30 NavarroSLChenYLiL UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables. Drug Metab Disposition. 2011;39(9):1650–1657. </plain></SENT>
</text></ref><ref id="bibr31-1559325817723731"><text><SENT sid="448" pm="."><plain>31 CritchleyJANimmoGRGregsonCA Inter-subject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol. 1986;22(6):649–657.3567011 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
